Spravato Treatment NYC
Experience the Revitalizing Power of Spravato, Covered by Insurance
Nushama currently accepts Optum (United Healthcare and Oxford) and Cigna, and will soon extend our coverage to Blue Cross Blue Shield, Aetna, Medicare, and other insurance providers.
What is Spravato?
Spravato (generic name esketamine), is a medication used by those with a depressive disorder who have not responded sufficiently to other forms of depression treatment. Molecularly, it is half of the molecular composition of ketamine, the s-isomer, hence the name s-ketamine or esketamine. Ketamine itself is a 60-year-old FDA-approved anesthetic. In the early 2000s, researchers began demonstrating ketamine’s rapid-acting antidepressant effects when provided intravenously in small doses.
Spravato, on the other hand, is administered as a nasal spray at our clinic in NYC and must be provided with an oral antidepressant. It is self-administered but only under the direct supervision of a licensed medical professional in a clinical setting. Spravato is typically given two times per week for the first month, followed by once a week ongoingly for maintenance treatment.
What Conditions Can Spravato Treat?
Spravato (Esketamine) Nasal Spray is FDA Approved for those who have been diagnosed with the following conditions:
Suicidal ideation or behaviors
How Does Spravato Treatment Work?
The exact mechanism by which esketamine produces its antidepressant effects is not fully understood. However, research suggests it may work by increasing neurotransmitters (chemicals that transmit signals in the brain), such as glutamate and GABA. It may also increase the formation of new connections between neurons, a process known as neuroplasticity.
The overall response rate to Spravato (esketamine) in the treatment of treatment-resistant depression (TRD) has been evaluated through various clinical trials, and the data show promising results, though responses vary based on patient characteristics and the length of treatment.
Potential Benefits of Spravato in NYC
One of the main benefits of ketamine nasal spray for depression is that it can be covered by insurance depending on your carrier and policy.
Additionally, it can rapidly improve symptoms, even in individuals who have not responded to other forms of treatment. Spravato may also be a useful option for individuals unable to take traditional antidepressants due to side effects or other contraindications. Spravato is effective approximately 40% of the time.
For those seeking Spravato treatment in NYC, this innovative option provides a promising alternative for managing treatment-resistant depression.
